Overview

Multicenter, Safety Study Of Maraviroc

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
To collect safety and tolerability data in a more diverse patient population of patients with HIV/Aids, who have limited therapeutic options.
Phase:
Phase 3
Details
Lead Sponsor:
ViiV Healthcare
Collaborator:
Pfizer
Treatments:
Maraviroc